Anemia Management: Iron

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis.

Topic Category: 
Article date: 
Sunday, April 1, 2012

 

Abstract

BACKGROUND AND AIMS:

Iron deficiency anemia (IDA) is a common problem in patients with Inflammatory Bowel Disease (IBD) and has a significant negative impact on quality of life. The aim was to compare the clinical efficacy of intravenous (IV) versus oral (PO) iron replacement in adult IBD with iron deficiency anemia (IDA).

METHODS:

Intravenous iron supplementation after kidney transplantation.

Topic Category: 
Article date: 
Thursday, March 8, 2012

 

Abstract

BACKGROUND:

We sought to evaluate the effect of intravenous (IV) iron supplementation on hemoglobin (Hb) levels and detect predictors for response.

METHODS:

This is a retrospective cohort study of 81 patients who were treated with IV iron post-transplant. We evaluated predictors of response to treatment defined as an increase in Hb value of more than 1 g/dL by linear regression analysis.

RESULTS:

Strategies to improve iron status in women at risk of developing anaemia.

Topic Category: 
Article date: 
Wednesday, January 18, 2012

 

Abstract

Iron deficiency is one of the most prevalent nutritional deficiency disorders worldwide, with teenage girls and women of childbearing age, especially pregnant and postpartum mothers, being most affected. Although supplements may be required in some instances, simple dietary and lifestyle changes may also help individuals to establish a healthy iron status. This article presents useful information that nurses and midwives can provide to women during particular life phases such as pregnancy, adolescence and old age to improve their iron status.

Anemia After Kidney Transplantation; Its Prevalence, Risk Factors, and Independent Association With Graft and Patient Survival: A Time-Varying Analysis.

Topic Category: 
Article date: 
Tuesday, February 28, 2012

 

Abstract

INTRODUCTION:

Posttransplant anemia and its association with transplant outcomes have not been properly studied.

METHODS:

We examined 530 renal allograft recipients transplanted at our center and followed up for 31.0±14.1 months. Hemoglobin (Hb), serum bicarbonate, and creatinine; use of erythropoiesis-stimulating agent (ESA) and iron; and immunosuppressive regimen data were obtained at multiple time points during 24-month posttransplant.

RESULTS:

Pages

Subscribe to RSS - Anemia Management: Iron